Original document(14 pages)  中文版
    The invention provides a dispersible tablet for activating blood and easing pain and its preparation process, which comprises disintegrating the natural copper in the components, coating the borneol, ethanol dissolving into liquid, coating Chinese angelica with cyclodextrin, extracting the dross twice with water, concentrating into extract, disintegrating frankincense and coating with cyclodextrin, water boiling the dross, alcohol depositing to obtain extraction liquor, alcohol extracting the dross again, depositing to obtain precipitation, preparing concentration liquor through disintegrating / water steeping the ground beetle, alcohol extracting Chinese angelica extract and pseudo-ginseng powder, water boiling and alcohol depositing frankincense extraction liquor, spray-drying, charging adjuvant into the material, mixing and tabletting.
Application Number
申请号
200310121669 Application Date
申请日
2003.12.24
Title 名称 Dispersible tablet for activating blood and easing pain and its preparation process
Publication Number
公开号
1631407 Publication Date
公开日
2005.06.29
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K35/78,A61K9/20,A61P29/00
Applicant(s) Name
申请人
Mao Youchang
Address 地址 330002
Inventor(s) Name 发明人 Mao Youchang
Attorney & Agent 代理人 shi xiujin

  
Preparation of tablets against dysmenorrhea
Preparation of double coptis root effervescent tablets
Preparing method for nourishing blood and tranquilization tablet
Preparation of sweet dream tablets
Antilipemic capsule preparing method
Rheumatic capsule preparing method
Fresh motherwort tablet preparing method
Preparation of immunoregulation effervescent tablets
Method for producing extract of fresh bamboo "zhu-li"
Integrated packing technolony and product for liquid and solid
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.